NeuroQuant brain and prostate MRI quantification

Organization
Cortechs.ai · United States
Solution Type
Ready Product / Solution
Collaboration
Licensing, Business Collaboration (Joint Venture)

1. Technology overview

Cortechs.ai is a neuroimaging software company with headquarters in San Diego, California, and says it has been quantifying for more than 18 years. It develops AI that turns routine MRI, PET and CT scans into standardized volumetric measurements.

The NeuroQuant suite covers brain segmentation and volumetrics, NeuroQuant MS lesion tracking, NeuroQuant Brain Tumor, Lesion Surveillance for ARIA, NeuroQuant PET and NeuroQuant CT, plus OnQ Prostate for prostate MRI. The company reports more than 1,500 institutions and availability in 44 countries, with scanner-vendor partners including Siemens Healthineers, Philips, GE HealthCare and Canon Medical.

2. Highlighted features & specifications

  • NeuroQuant: brain segmentation and volumetrics with longitudinal tracking.
  • NeuroQuant MS: lesion visualization and volume change for multiple sclerosis.
  • Lesion Surveillance: FLAIR, T2*GRE and SWI lesion monitoring, including ARIA.
  • NeuroQuant PET: tracer quantification, FDA-cleared in August 2026.
  • NeuroQuant Brain Tumor: pre- and post-operative volume analysis.
  • OnQ Prostate: prostate MRI analysis with restriction spectrum imaging mapping.

3. Potential application

Neurology departments in Vietnam could track brain atrophy and MS lesions between MRI follow-ups. Imaging centers could add prostate MRI quantification to their reports. Hospitals joining an AI platform such as CARPL.ai could deploy NeuroQuant alongside other tools.

4. Benefits

Turns routine scans into standardized volumes that support objective reads.

Expanded EU MDR CE marking for NeuroQuant version 5 allows sale across the European Economic Area.

Available through scanner-vendor and AI-marketplace channels, reducing integration effort.

SOC 2 compliant, with a public trust center.

6. Other information

Headquarters at 5060 Shoreham Place, San Diego, California. Expanded EU MDR CE marking for NeuroQuant version 5 reported in August 2026; NeuroQuant PET received FDA 510(k) clearance in August 2026. Customers listed include MD Anderson, Johns Hopkins Medicine and Cedars-Sinai.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us